SUBSCRIBE
SUBSCRIBE
News   Drug Development

France’s Ipsen Buys Biotech Firm Sterix

October 19, 2005 | 
1 min read
Private French drugmaker Ipsen said on Thursday it had acquired a small British biotechnology firm prior to a possible initial public offering, in the latest sign of a pick-up in activity in the European sector.
Clinical research Phase 1 IPO Mergers & acquisitions
MORE ON THIS TOPIC
Working man icon pushing the load on the line. Hard work, labor, effort and determination concept.
Immunology and inflammation
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
August 25, 2026
 · 
1 min read
 · 
Tristan Manalac
Hand Marking Calendar Reminder Illustration. A professional hand uses a pen to circle a date on a red and white calendar, representing schedule planning and important reminders
FDA
Capricor’s Duchenne therapy has new life after FDA grants 3-month extension
August 24, 2026
 · 
2 min read
 · 
Heather McKenzie
Row of Falling Domino Stones Stopped by Red Domino Stone Over Black Background, Risk Management, Intervene or Prevention Concept, 3d Rendering
FDA
REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans
August 24, 2026
 · 
2 min read
 · 
Heather McKenzie
Time on the hourglass stopped. Clock on table. Pause in business, collapse.
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
August 24, 2026
 · 
1 min read
 · 
Tristan Manalac